Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies


Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Ed Pezalla, MD, MPH, discuss determining and recognizing utilization management for long-term systemic therapies in patients with atopic dermatitis.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.